Soluble Adhesion Molecules in Colorectal Cancer Patients
Author Information
Author(s): G Velikova, RE Banks, A Gearing, I Hemingway, MA Forbes, SR Preston, NR Hall, M Jones, J Wyatt, K Miller, U Ward, J Al-Maskattil, SM Singh, P Finan, NS Ambrose, JN Primrose, PJ Selby
Primary Institution: ICRF Cancer Medicine Research Unit, St James's University Hospital
Hypothesis
The study investigates the concentrations of soluble adhesion molecules in patients with colorectal cancer and their relation to clinical parameters.
Conclusion
Serum concentrations of ICAM-1 and VCAM-1 are significantly elevated in colorectal cancer patients compared to healthy subjects.
Supporting Evidence
- ICAM-1 and VCAM-1 levels were significantly elevated in colorectal cancer patients compared to healthy subjects.
- Circulating ICAM-1 and VCAM-1 were increased in both local and metastatic disease.
- Some patients had high concentrations of E-cadherin and E-selectin, but these were not significantly elevated compared to controls.
Takeaway
Doctors looked at blood samples from people with colorectal cancer to see if certain proteins were higher than in healthy people, and they found that two proteins were much higher in cancer patients.
Methodology
Blood samples were taken from patients before treatment to measure levels of soluble adhesion molecules using ELISA kits.
Potential Biases
The analysis was biased by missing data on grading of differentiation, inflammation, and ulceration.
Limitations
The study had missing data on grading of differentiation, inflammation, and ulceration, which may have biased the results.
Participant Demographics
Median age of patients was 70 years, with 19 females and 29 males.
Statistical Information
P-Value
p<0.00001
Statistical Significance
p<0.00001
Want to read the original?
Access the complete publication on the publisher's website